Pitchkit
  • Docs
  • Pricing
  • Blog
  • Tools
  • Investors
Sign inGet started
Pitchkit

Structure and stress-test your pitch with workflows built from 6+ years of VC dealflow.

Product

  • Overview
  • Pitch deck feedback
  • Pitch deck generator
  • Templates
  • Pricing

Resources

  • Learn
  • Pitch by stage
  • Slide guides
  • Docs
  • Glossary
  • Free tools

Company

  • About
  • Blog
  • Changelog
  • Contact
  • Privacy policy

Ready to pitch?

Start building your investor-ready pitch today. Free forever, no credit card required.

Start free

© 2026 Pitchkit / edgelord.tech

All systems operational
Pitchkit
Back to investor directory
Corporate VC
Spain

Caixa Capital Risc

Investment focus

Sectors

Biotech
Healthtech
Medtech
Deeptech
SaaS
Cleantech

Investment stages

Seed
Series A
Series B

Geographic focus

Spain
Europe
Portugal

Investment thesis

Venture capital arm of CriteriaCaixa (la Caixa Foundation), backing innovative tech and life sciences startups primarily in Spain and Portugal from seed to growth since 2004, with 100+ portfolio companies.

Typical check size

€500k – €3M

Fund size: €144M (across life sciences and tech funds)

Browse similar check sizes →

Portfolio highlights

Tebrio - insect protein and circular bioeconomy company
NRG Therapeutics - biotech focused on mitochondrial neurodegenerative diseases
AptaTargets - RNA aptamer-based cancer therapeutics
AbolerIS Pharma - biopharmaceutical therapies for metabolic diseases

Contact

www.criteriacaixa.com
Spain

Research with AI

Learn more about Caixa Capital Risc using AI:

Ask ChatGPTAsk Perplexity

Pitch guides

Learn what Caixa Capital Risc and similar investors look for:

Biotech pitch guideHealthtech pitch guideMedtech pitch guide

More investors in Spain

Acurio VenturesAxon Partners GroupBonsai PartnersDemiumView all in Spain

Related resources

Seed fundraising guideSeed pitch deck guideSeries A fundraising guideSeries A pitch deck guideSeries B fundraising guideSaaS pitch deck by model

More Biotech investors

AbingworthACF InvestorsAhren Innovation CapitalAlmi Invest GreenTechView all Biotech investors